(18)F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study. Burggraaff CN, Eertink JJ, Lugtenburg PJ, Hoekstra OS, et al. J Nucl Med 2021 Oct 21. pii: jnumed.121.262205. doi: 10.2967/jnumed.121.262205.

Read + Share

Amedeo Smart

Independent Medical Education

Burggraaff CN, Eertink JJ, Lugtenburg PJ, Hoekstra OS, et al. (18)F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study. J Nucl Med 2021 Oct 21. pii: jnumed.121.262205. doi: 10.2967/jnumed.121.262205.
PMID: 34675112